A zwitterionic dual-network hydrogel patch with anti-inflammatory properties for efficient peritoneal adhesion
Yangrui Du1, Li Ma1, Shiying Lang1
1College of Biomass Science and Engineering, Sichuan University, Chengdu 610065, China. lgy3506@scu.edu.cn.
Abstract:
Postoperative peritoneal adhesion, driven by inflammatory response and fibrotic deposition, remains the most common complication following abdominal surgeries, with limited effective solutions. Herein, a dual-network hydrogel patch (GPSB) is developed for effective peritoneal adhesion prevention through interpenetrating a gelatin network with a zwitterionic polysulfobetaine (PSB) network. The biodegradable gelatin network is dynamically crosslinked via zinc ion (Zn2+)-polyphenol coordination, endowing the patch with inherent antibacterial and pro-healing activities. Through in situ polymerization, a crosslinked PSB network is interwoven with the gelatin matrix, markedly increasing the Young's modulus of hydrogels to 97.7 ± 5.2 kPa and greatly enhancing their mechanical integrity. Moreover, the resulting GPSB hydrogel achieves a shear strength of 28.5 kPa, on par with commercial cyanoacrylate-based bio-glues. Moreover, the highly biocompatible PSB component effectively resists nonspecific protein adsorption by 46-fold and modulates macrophage-mediated inflammatory responses, reducing the secretion of inflammatory cytokines by approximately 70%. Through the synergistic antibacterial and anti-inflammatory functions, the GPSB hydrogel patch provides robust protection against postoperative inflammation and achieves efficient prevention of peritoneal adhesions. This study highlights an effective and multifunctional hydrogel patch for next-generation anti-adhesion biomaterials.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...


